Page last updated: 2024-10-27

flurbiprofen and Medulloblastoma

flurbiprofen has been researched along with Medulloblastoma in 1 studies

Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.

Medulloblastoma: A malignant neoplasm that may be classified either as a glioma or as a primitive neuroectodermal tumor of childhood (see NEUROECTODERMAL TUMOR, PRIMITIVE). The tumor occurs most frequently in the first decade of life with the most typical location being the cerebellar vermis. Histologic features include a high degree of cellularity, frequent mitotic figures, and a tendency for the cells to organize into sheets or form rosettes. Medulloblastoma have a high propensity to spread throughout the craniospinal intradural axis. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2060-1)

Research Excerpts

ExcerptRelevanceReference
" In an attempt to find an effective treatment, we examined the efficacy of the non-steroidal anti-inflammatory drug, flurbiprofen, to suppress the growth of tumor cell lines derived from medulloblastoma and glioblastoma multiforme."3.71Inhibition of human brain tumor cell growth by the anti-inflammatory drug, flurbiprofen. ( Khalili, K; King, JG, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
King, JG1
Khalili, K1

Other Studies

1 other study available for flurbiprofen and Medulloblastoma

ArticleYear
Inhibition of human brain tumor cell growth by the anti-inflammatory drug, flurbiprofen.
    Oncogene, 2001, Oct-18, Volume: 20, Issue:47

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Brain Neoplasms; Cell Cycle; Cell Division; Cyclin B; Cyclo

2001